RT journal article
T1 Effectiveness of Percutaneous Electrolysis in Supraspinatus Tendinopathy: A Single-Blinded Randomized Controlled Trial
A1 Rodríguez Huguet, Manuel
A1 Góngora Rodríguez, Jorge Manuel
A1 Rodríguez-Huguet, Pablo
A1 Ibañez-Vera, Alfonso Javier
A1 Rodríguez-Almagro, Daniel
A1 Martín Valero, Rocío
A1 Díaz-Fernández, Ángeles
A1 Lomas-Vega, Rafael
A2 Enfermería y Fisioterapia
K1 supraspinatus tendinopathy
K1 percutaneous electrolysis
K1 trigger point dry needling
K1 shoulder pain
AB Supraspinatus tendinopathy is one of the most common causes of shoulder pain. Many studies support conservative treatments such as exercise, trigger point dry needling or corticosteroid injections. Otherwise, a minimally invasive approach with percutaneous electrolysis (PE) has also been used successfully in shoulder pain, although evidence about its long-term effects is scarce. The aim of this trial was to determine the effects of PE on supraspinatus tendinopathy compared with trigger point dry needling (TDN). Thirty-six patients with supraspinatus tendinopathy were randomly assigned to either a PE group (n=18) or a TDN group (n=18). Both groups also performed eccentric exercises. The main outcome to be measured was the Numerical Pain Rating Scale (NPRS), but the shoulder range of motion (ROM) and trigger point pressure pain threshold (PPT) were also considered. A one-year follow-up was conducted. Significant differences favoring the PE group were found regarding pain at one-year follow-up (p=0.002). The improvement achieved in the PE group was greater in the NPRS (p<0.001), proximal PPT, middle PPT, distal PPT (all p<0.001) and ranges of movement. PE seems to be more effective than TDN in relieving pain and improving ROM and PPT supraspinatus values in patients with supraspinatus tendinopathy, both right after treatment and at one-year follow-up.
PB MDPI
SN 2077-0383
YR 2020
FD 2020-06
LK http://hdl.handle.net/10498/23608
UL http://hdl.handle.net/10498/23608
LA eng
DS Repositorio Institucional de la Universidad de Cádiz
RD 11-nov-2026